Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 32

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

Clinical Trial Readiness for SCA1 and SCA3
Spinocerebellar Ataxia 3Spinocerebellar Ataxia Type 1
PrincipalinvestigatorStart date: 2018-08-16

Research Network

Collaboration Network

32 collaborators·78 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, Los Angeles

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

George Wilmot, MD, PhD

Emory University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Talene Yacoubian, MD, PhD

University of Alabama at Birmingham

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Puneet Opal, MD, PhD

Northwestern University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

SH Subramony, MD

University of Florida

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Haris I Sair, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Peter Morrison, DO

University of Rochester

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Vikram Shakkottai, MD, PhD

University of Texas

Related
2 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Peter Barker, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Chiadikaobi Onyike, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Sharon Sha

Stanford University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03487367PrincipalInvestigator

Clinical Trial Readiness for SCA1 and SCA3

Spinocerebellar Ataxia 3Spinocerebellar Ataxia Type 1
Unknown
NCT00537680Phase 3PrincipalInvestigator

Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia

Friedreich's Ataxia
Completed
NCT00697073Phase 3PrincipalInvestigator

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

Friedreich's Ataxia
Completed

All 3 trials loaded